ECHO THERAPEUTICS Aktie

1,32 EUR 0,6875%

Zu Ihrem Onlinebroker

kaufen verkaufen

ECHO THERAPEUTICS Aktienkurs : 25.05. ( 15 Min. verzögert)
1,32 € Letzter Kurs	0,69% Veränderung	1,31 € Vortag	1,32 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
1,32 - 1,32 Tag	3,25 - 1,21 52 Wochen	0 Tag	154 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

ECHO THERAPEUTICS Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

22.05.

Smokers in China tip the scale in med-tech's favor | Wall Street Beat

... heart device makers; also, don't forget reimbursement, says a Bayer exec; device makers keep a cool head in a tough market; Echo Therapeutics spikes deal with MLV & Co.; DSM commences ...
17.05.

Abiomed swings to 2011 black on record Q4 revenues | Earnings Roundup

... a heavy hit on reimbursement challenges; Bovie touts strong sales growth, shrinking profits; Cambridge Heart spends another quarter in the red; Echo Therapeutics narrows losses amid shrinking sales; and InVivo jumps into the black.

14.05.

Feltl & Co. Lowers Echo Therapeutics to Buy (ECTE)

Echo Therapeutics (NASDAQ: ECTE) was downgraded by investment analysts at Feltl & Co. from a “strong-buy” rating to a “buy” rating in a note issued to investors on Monday. They currently have a $…
11.05.

Echo Therapeutics Q1 Loss Narrows

(RTTNews) - Echo Therapeutics (ECTE: News ) reported a net loss applicable to common shareholders of $3.0 million or $0.08 per share, narrower than...
11.05.

Echo Therapeutics Announces First Quarter 2012 Financial Results

PHILADELPHIA, May 11, 2012 /PRNewswire via COMTEX/ -- Echo Therapeutics, Inc. (UTD:ECTE) , a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system...